Macitentan
Back to searchMolecule Structure
Scientific Name
Macitentan
Description of the Drug
Macitentan is an endothelin receptor antagonist used to manage pulmonary arterial hypertension to delay disease progression.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08932
http://www.drugbank.ca/drugs/DB08932
Brand Name(s)
Opsumit
Company Owner(s)
Zydus Worldwide Dmcc, Actelion Pharmaceuticals Us Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Endothelin receptor, ET-A/ET-B | PROTEIN FAMILY | ANTAGONIST | CHEMBL2096678 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1445625 | |
DrugBank | DB08932 | |
PubChem: Thomson Pharma | 24380756 | |
PubChem | 16004692 | |
LINCS | LSM-45420 | |
Nikkaji | J2.832.870B | |
BindingDB | 50395626 | |
EPA CompTox Dashboard | DTXSID50196063 | |
DrugCentral | 4809 | |
Guide to Pharmacology | 7352 | |
rxnorm | MACITENTAN | OPSUMIT |
ChEBI | 76607 | |
ZINC | ZINC000043202140 |